ArticleHaematologica2025

Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia.

Shanna M Hogeling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.